2A Pharma Initiates Phase 1 Clinical Trial of HPV Vaccine Candidate

Press Release Malmö, Sweden – 13 March 20192A Pharma, the Swedish/Danish vaccine company today announced that, approximately 27 months after the company was founded, its novel, broad coverage, HPV L2 vaccine candidate formulated without adjuvant, has progressed into a phase 1 clinical trial and dosing of the sentinel group is completed. The first-in-human, phase 1, […]